Dental professionals' knowledge, attitudes, and practice behaviors related to human papillomavirus vaccination.
Oropharyngeal neoplasms
dental hygienists
dentists
human papillomavirus infections
human papillomavirus vaccines
practice patterns
Journal
Journal of public health dentistry
ISSN: 1752-7325
Titre abrégé: J Public Health Dent
Pays: United States
ID NLM: 0014207
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
25
04
2019
revised:
26
08
2019
accepted:
27
10
2019
pubmed:
4
12
2019
medline:
31
7
2020
entrez:
3
12
2019
Statut:
ppublish
Résumé
In Arizona, human papillomavirus (HPV)-related cancers are declining, with the exception of oropharyngeal cancer (OPC). HPV-related OPC is largely caused by persistent infection with oncogenic HPV strains, many of which the 9-valent HPV vaccine offers protection. Little is known about dental professionals' willingness to promote the HPV vaccine to prevent OPC. The current study assessed Arizona dental professionals' knowledge, attitudes, willingness, and current practice behaviors related to HPV vaccine promotion. Responses between dentists and hygienists were also compared. A convenience sample of 711 dentists and hygienists attending a regional conference were recruited and asked to complete a 34-item survey assessing knowledge and attitudes about HPV, the HPV vaccine, HPV-related OPC, and their willingness to promote and administer the HPV vaccine. Fisher's exact tests and Mann-Whitney U tests were used for data analysis. Most respondents answered HPV knowledge questions correctly but did not know HPV-related OPC has a more favorable prognosis than other head and neck cancers. Dentists were more confident discussing and recommending the HPV vaccine. Both dentists and hygienists were willing to refer patients to their non-dental primary care providers for vaccination; however, they were less confident in administering the vaccine if it fell within their scope of practice. They reported willingness to receive training to recommend the vaccine. Given the willingness of respondents to receive training related to HPV vaccine communication, future research should develop and test talking points and communication training to aid dentists and hygienists in their promotion of the HPV vaccine.
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
61-69Informations de copyright
© 2019 American Association of Public Health Dentistry.
Références
Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus-associated cancers: United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2018;67(33):918-24.
American Joint Committee on Cancer. Cancer staging manual, 7th ed. New York: Springer; 2010.
Gollin SM. Epidemiology of HPV-associated oropharyngeal squamous cell carcinoma. In: Miller DL, Stack MS, editorsHuman papillomavirus (HPV)-associated oropharyngeal cancer. Switzerland: Springer; 2015. p. 1-23.
National Cancer Institute Surveillance Epidemiology and End Results Program. Cancer stat facts: oral cavity and pharynx cancer. 2018 [cited 2018 May 21]. Available from: https://seer.cancer.gov/statfacts/html/oralcav.html.
Arizona Department of Health Services Arizona Cancer Registry. Profile of oropharyngeal cases in Arizona. 2018 [cited 2019 April 12]. Available from: https://www.azdhs.gov/documents/preparedness/public-health-statistics/cancer-registry/reports/oropharyngeal-cancer-data-profile.pdf.
Airzona Department of Health Services. Arizona Cancer Registry. 2019 [cited 2019 April 12]. Available from: https://www.azdhs.gov/preparedness/public-health-statistics/cancer-registry/index.php.
Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14-26.
Merck Sharp and Dohme Corp. Highlights of prescribing information. Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) 2006-2018 [cited 2019 April 12]. Available from: https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_pi.pdf.
Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, Bosch FX, de Sanjosé S, Trottier H. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319-31.
Meites E, Kempe A, Markowitz L. Use of a 2-dose schedule for human papillomavirus vaccination: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405-8.
Healthy Poeple 2020. Immunization and infectious diseases. 2010 [cited 2019 January 22]. Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives.
Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years: United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(33):909-17.
American Dental Association. Statement on human papillomavirus and cancers of the oral cavity and oropharynx. 2013 [cited 2018 May 21]. Available from: http://www.ada.org/en/about-the-ada/ada-positions-policies-and-statements/statement-on-human-papillomavirus-and-squamous-cel.
Lingen MW, Abt E, Agrawal N, Chaturvedi AK, Cohen E, D'Souza G et al. Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American dental association. J Am Dent Assoc. 2017;148(10):712-27.e10.
Vázquez-Otero C, Vamos CA, Thompson EL, Merrell LK, Griner SB, Kline NS, Catalanotto FA, Giuliano AR, Daley EM. Assessing dentists' human papillomavirus-related health literacy for oropharyngeal cancer prevention. J Am Dent Assoc. 2018;149(1):9-17.
Walker K, Jackson R, Sommariva S, Neelamegam M, Desche J. USA dental health providers' role in HPV vaccine communication and HPV-OPC protection: a systematic review. Hum Vaccin Immunother. 2019. [Epub 2019 Jan 8];15:1863-9.
Kline N, Vamos C, Thompson E, Catalanotto F, Petrila J, DeBate R, Griner S, Vázquez-Otero C, Merrell L, Daley E. Are dental providers the next line of HPV-related prevention? Providers' perceived role and needs. Papillomavirus Res. 2018;5:104-8.
Thompson EL, Daley EM, Vamos CA, Horowitz AM, Catalanotto FA, DeBate RD, Merrell LK, Griner SB, Vazquez-Otero C, Kline NS. Health literacy approaches to improving communication between dental hygienists and patients for HPV-related oral cancer prevention. J Dent Hyg. 2017;91(4):37-45.
Oregon State Legislature. 2019. HP 2220. [cited 2019 Aug 1]. Available from: https://olis.leg.state.or.us/liz/2019R1/Measures/Overview/HB220.
Dodd RH, Forster AS, Waller J, Marlow LA. Discussing HPV with oropharyngeal cancer patients: a cross-sectional survey of attitudes in health professionals. Oral Oncol. 2017;68:67-73.
Rutkoski H, Fowler B, Mooney R, Pappas L, Dixon BL, Pinzon LM, Winkler J, Kepka D. Pilot test of survey to assess dental and dental hygiene student human papillomavirus-related oropharyngeal cancer knowledge, perceptions, and clinical practices. J Cancer Educ. 2018;33(4):907-14.
Rowan S, Hu S, Brotzman J, Redding S, Rankin K, Vigneswaran N. Knowledge assessment of the dental community in Texas on the role of human papilloma virus in oropharyngeal cancer. Tex Dent J. 2015;132(8):528-36.
Daley EM, Thompson EL, Vamos CA, Griner SB, Vazquez-Otero C, Best AL, Kline NS, Merrell LK. HPV-related knowledge among dentists and dental hygienists. J Cancer Educ. 2018;33(4):901-6.
Arora S, Ramachandra SS, Squier C. Knowledge about human papillomavirus (HPV) related oral cancers among oral health professionals in university setting: a cross sectional study. J Oral Biol Craniofac Res. 2018;8(1):35-9.
Griner SB, Thompson EL, Vamos CA, Chaturvedi AK, Vazquez-Otero C, Merrell LK et al. Dental opinion leaders' perspectives on barriers and facilitators to HPV-related prevention. Hum Vaccin Immunother. 2019;15(7-8):1856-62.
Daley EM, Vamos CA, Thompson E, Vázquez-Otero C, Griner SB, Merrell L, Kline N, Walker K, Driscoll A, Petrila J. The role of dental providers in preventing HPV-related diseases: a systems perspective. J Dent Educ. 2019;83(2):161-72.
Daley E, Dodd V, DeBate R, Vamos C, Wheldon C, Kline N, Smith S, Chandler R, Dyer K, Helmy H, Driscoll A. Prevention of HPV-related oral cancer: assessing dentists' readiness. Public Health. 2014;128(3):231-8.
Naleway AL, Henninger ML, Waiwaiole LA, Mosen DM, Leo MC, Pihlstrom DJ. Dental provider practices and perceptions regarding adolescent vaccination. J Public Health Dent. 2018;78(2):159-64.
Paquette DW, Bell KP, Phillips C, Offenbacher S, Wilder RS. Dentists' knowledge and opinions of oral-systemic disease relationships: relevance to patient care and education. J Dent Educ. 2015;79(6):626-35.
Arizona Administrative Code. R4-23-411. Pharmacist-administered or Pharmacy or Graduate Intern-administered Immunizations. 2018 [cited 2018 Sept 28]. Available from: https://pharmacy.az.gov/sites/default/files/documents/files/immunization%20rule.pdf